Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers

Annals of Nuclear Medicine

Volumn 29, Issue 1, 2015, Pages 91-99

  Bajc, Marika ^a   Markstad, Hanna ^a   Jarenbäck, Linnea ^a   Tufvesson, Ellen ^a   Bjermer, Leif ^a   Jögi, Jonas ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chronic obstructive pulmonary disease (COPD); Imaging interpretation criteria; Pulmonary scintigraphy; Technegas; Ventilation Perfusion SPECT

Indexed keywords

AEROSOL; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CT SPECT SCANNER; FEMALE; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE CLASSIFICATION; HEART LEFT VENTRICLE FAILURE; HUMAN; LUNG CONGESTION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDUAL VOLUME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SPIROMETRY; THIN LAYER CHROMATOGRAPHY; TOTAL LUNG CAPACITY; LUNG; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY;

AGED; AIRWAY OBSTRUCTION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84926058822     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-014-0913-y     Document Type: Article

References (33)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.
2. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46.
3. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5):598–604.
4. Lofdahl CG. COPD and co-morbidities, with special emphasis on cardiovascular conditions. Clin Respir J. 2008;2(Suppl 1):59–63.
5. Wedzicha JA, Hurst JR. Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism. Thorax. 2007;62(2):103–4.
6. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–53.
7. Jarenbäck L, Ankerst J, Bjermer L, Tufvesson E. Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion, and resistance. Pulm Med. 2013;2013:782052.
8. Schuster DP. The opportunities and challenges of developing imaging biomarkers to study lung function and disease. Am J Respir Crit Care Med. 2007;176(3):224–30.
9. Begic A, Jögi J, Hadziredzepovic A, Kucukalic-Selimovic E, Begovic-Hadzimuratovic S, Bajc M. Tomographic ventilation/perfusion lung scintigraphy in the monitoring of the effect of treatment in pulmonary embolism: serial follow-up over a 6-month period. Nucl Med Commun. 2011;32(6):508–14.
10. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM guidelines for ventilation/perfusion scintigraphy: part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT. Eur J Nucl Med Mol Imaging. 2009;36(9):1528–38.
11. Bajc M, Olsson B, Palmer J, Jonson B. Ventilation/Perfusion SPECT for diagnostics of pulmonary embolism in clinical practice. J Intern Med. 2008;264(4):379–87.
12. Jögi J, Jonson B, Ekberg M, Bajc M. Ventilation-perfusion SPECT with 99mTc-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J Nucl Med. 2010;51(5):735–41.
13. Jögi J, Ekberg M, Jonson B, Bozovic G, Bajc M. Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT. Eur J Nucl Med Mol Imaging. 2011;38(7):1344–52.
14. Satoh K, Nakano S, Tanabe M, Nishiyama Y, Takahashi K, Kobayashi T, et al. A clinical comparison between Technegas SPECT, CT, and pulmonary function tests in patients with emphysema. Radiat Med. 1997;15(5):277–82.
15. Jobse BN, Rhem RG, McCurry CA, Wang IQ, Labiris NR. Imaging lung function in mice using SPECT/CT and per-voxel analysis. PLoS ONE. 2012;7(8):e42187.
16. Norberg P, Persson HL, Carlsson GA, Bake B, Kentson M, Sandborg M, et al. Quantitative lung SPECT applied on simulated early COPD and humans with advanced COPD. EJNMMI research. 2013;3(1):28.
17. Olsson CG, Bitzen U, Olsson B, Magnusson P, Carlsson, Jonson B, et al. Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy. Med Sci Monit. 2006;12(2):PI9–13.
18. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13.
19. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123(6):659–64.
20. Standardization of Spirometry, 1994 Update. American thoracic society. Am J Respir Crit Care Med. 1995;152(3):1107–36.
21. Bergin C, Muller N, Nichols DM, Lillington G, Hogg JC, Mullen B, et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis. 1986;133(4):541–6.
22. Bankier AA, De Maertelaer V, Keyzer C, Gevenois PA. Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology. 1999;211(3):851–8.
23. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging. 2009;36(8):1356–70.
24. Palmer J, Bitzen U, Jonson B, Bajc M. Comprehensive ventilation/perfusion SPECT. J Nucl Med. 2001;42(8):1288–94.
25. Elf JE, Jögi J, Bajc M. Home treatment of patients with small to medium sized acute pulmonary embolism. J Thromb Thrombolysis. 2014. doi:10.1007/s11239-014-1097-y.
26. Jögi J, Palmer J, Jonson B, Bajc M. Heart failure diagnostics based on ventilation/perfusion single photon emission computed tomography pattern and quantitative perfusion gradients. Nucl Med Commun. 2008;29(8):666–73.
27. Pellegrino R, Biggi A, Papaleo A, Camuzzini G, Rodarte JR, Brusasco V. Regional expiratory flow limitation studied with Technegas in asthma. J Appl Physiol. 2001;91(5):2190–8.
28. Taplin GV, Tashkin DP, Chopra SK, Anselmi OE, Elam D, Calvarese B, et al. Early detection of chronic obstructive pulmonary disease using radionuclide lung-imaging procedures. Chest. 1977;71(5):567–75.
29. Timmins SC, Diba C, Farrow CE, Schoeffel RE, Berend N, Salome CM, et al. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest. 2012;142(2):312–9.
30. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–55.
31. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):543–8.
32. Estepar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, et al. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188(2):231–9.
33. Jobse BN, Rhem RG, Wang IQ, Counter WB, Stampfli MR, Labiris NR. Detection of lung dysfunction using ventilation and perfusion SPECT in a mouse model of chronic cigarette smoke exposure. J Nucl Med. 2013;54(4):616–23.